Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

47.46 -0.50 (-1.04%)
Official Closing Price Updated: 7:00 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation With the Schall Law Firm
From The Schall Law Firm
Via Business Wire
HIMS & HERS HEALTH INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims on Behalf of Investors of Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via Business Wire
HIMS BREAKING NEWS: Hims & Hers Health, Inc. is being Investigated for Securities Fraud; Investors with Losses are Notified to Contact BFA Law
From Bleichmar Fonti & Auld LLP
Via Business Wire
HIMS Stock Alert: Kehoe Law Firm, P.C. Investigating Potential Securities Fraud Claims on Behalf of Investors of Hims & Hers Health, Inc.
Via ACCESS Newswire
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – HIMS
From DJS Law Group
Via Business Wire
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
NYSE: HIMS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Significant Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers
From Faruqi & Faruqi, LLP
Via Business Wire
Rosen Law Firm Encourages Hims & Hers Health, Inc. Investors to Inquire About Securities Class Action Investigation – HIMS
From The Rosen Law Firm, P.A.
Via Business Wire
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
From Hims & Hers
Via Business Wire
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
From Hims & Hers
Via Business Wire
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
From Hims & Hers
Via Business Wire
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
From Hims & Hers
Via Business Wire
Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care
From Hims & Hers
Via Business Wire
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
From Hims & Hers
Via Business Wire
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
From Defiance ETFs
Via GlobeNewswire
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
From Hims & Hers
Via Business Wire
Hims & Hers Acquires US-based Peptide Facility
From Hims & Hers
Via Business Wire
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
From Hims & Hers
Via Business Wire
Hims & Hers Launches Health Collective and Community Member Council
From Hims & Hers
Via Business Wire
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
From Hims & Hers
Via Business Wire
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
From Hims & Hers
Via Business Wire
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
From Hims & Hers
Via Business Wire
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
From Hims & Hers
Via Business Wire
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
From Hims & Hers
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.